Table:
begin	end	state
1	6	cytoplasmic
7	35	transmembrane
36	54	non-cytoplasmic
55	75	transmembrane
76	82	cytoplasmic
83	108	transmembrane
109	112	non-cytoplasmic
113	131	transmembrane
132	137	cytoplasmic
138	162	transmembrane
163	170	non-cytoplasmic
171	193	transmembrane
194	212	cytoplasmic
213	235	transmembrane
236	240	non-cytoplasmic
241	258	transmembrane
259	277	cytoplasmic
278	297	transmembrane
298	306	non-cytoplasmic
307	327	transmembrane
328	338	cytoplasmic
339	362	transmembrane
363	368	non-cytoplasmic
369	398	transmembrane
399	404	cytoplasmic
405	428	transmembrane
429	429	non-cytoplasmic
430	453	transmembrane
454	467	cytoplasmic

Input:
>GFF2033
MDVVLLFSMVIGLLLIGVPIAVALGLSSTLFLLIYSDSSLASVAGTLFEAFEGHFTLLAI
PFFILASSFMTTGGVARRIIRFSIACVGHLPGGLAIAGVFACMLFAALSGSSPATVVAIG
SIVIAGMRQVGYSKEFAAGVICNAGTLGILIPPSIVMVVYAAAVEVSVGRMFLAGVIPGL
MAGLMLMVTIYVMAKVKNLPKGEWLGWGEVAASAANASVGLLLIGIILGGIYGGIFTPTE
AAAVASVYAFFVATFVYRDMGPLKSAPKPKDMGQFLTMLPKMLGQTVVYFIPSFFHADTR
HALFEAGKLTVTLLFVIANALILKHVLTDEQVPQQIATAMLSAGFGPVMFLIVVNVILLI
GGQFMEPSGLLVIVAPLVFPIAIELGIDPIHLGIIMVVNMEIGMITPPVGLNLFVTSGVA
GMPMMAVVRAALPFLAVLFVFLIMITYIPWISTVLPNAVMGPEIITK

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server